AR051288A1 - Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica - Google Patents
Derivados de pirazol condensado, su preparacion y su aplicacion terapeuticaInfo
- Publication number
- AR051288A1 AR051288A1 ARP050103775A ARP050103775A AR051288A1 AR 051288 A1 AR051288 A1 AR 051288A1 AR P050103775 A ARP050103775 A AR P050103775A AR P050103775 A ARP050103775 A AR P050103775A AR 051288 A1 AR051288 A1 AR 051288A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- radical
- alkoxy
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se refiere a derivados de pirazol condensado, procedimientos de preparacion y aplicacion en terapéutica. Reivindicacion 1: Compuesto que responde a la formula (1) en la que: A representa un radical alquileno C3-5 lineal no sustituido o sustituido una o varias veces por un alquilo C1-3; un radical -CH2-CH2-O-CH2-; W representa un enlace directo o un radical -CH2-; R1 representa un átomo de H o un alquilo C1-3; R2 representa un alquilo C1-10 no sustituido o sustituido una o varias veces por un átomo de halogeno; un grupo -B-R4; R3 representa un fenilo sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo, un radical trifluorometoxi, un naftilo no sustituido o sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo; un quinolilo no sustituido o sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo; B representa un enlace directo o u radical alquileno C1-2 no sustituido o sustituido una o varias veces por un alquilo C1-3; R4 representa un fenilo no sustituido o sustituido por uno o varios sustituyentes elegidos independientemente entre un átomo de halogeno, un alquilo C1-4, un alcoxi C1-4, un radical trifluorometilo; un radical carbocíclico no aromático C3-12, no sustituido o sustituido una o varias veces por un alquilo C1-4 o un alcoxi C1-4; un 1,2,3,4-tetrahidronaftalen-1-ilo, en el estado de base, así como en el estado de hidrato o de solvato.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0409712A FR2875230A1 (fr) | 2004-09-13 | 2004-09-13 | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
AR051288A1 true AR051288A1 (es) | 2007-01-03 |
Family
ID=34954413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050103775A AR051288A1 (es) | 2004-09-13 | 2005-09-09 | Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR051288A1 (es) |
FR (1) | FR2875230A1 (es) |
PE (1) | PE20060627A1 (es) |
TW (1) | TW200621786A (es) |
UY (1) | UY29112A1 (es) |
WO (1) | WO2006030124A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7923465B2 (en) | 2005-06-02 | 2011-04-12 | Glenmark Pharmaceuticals S.A. | Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
EP1902034B1 (en) * | 2005-06-02 | 2011-03-30 | Glenmark Pharmaceuticals S.A. | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
WO2007001939A1 (en) * | 2005-06-27 | 2007-01-04 | Janssen Pharmaceutica N.V. | Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities |
US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
KR20080050522A (ko) * | 2005-09-23 | 2008-06-05 | 얀센 파마슈티카 엔.브이. | 헥사하이드로-사이클로헵타피라졸 카나비노이드 모듈레이터 |
US7825151B2 (en) | 2005-09-23 | 2010-11-02 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
WO2007038045A1 (en) * | 2005-09-23 | 2007-04-05 | Janssen Pharmaceutica, N.V. | Tetrahydro-indazolyl cannabinoid modulators |
EP1937646A1 (en) * | 2005-09-23 | 2008-07-02 | Janssen Pharmaceutica N.V. | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
NZ567006A (en) * | 2005-09-23 | 2010-11-26 | Janssen Pharmaceutica Nv | Hexahydro cyclooctyl pyrazole cannabinoid modulators |
US8378096B2 (en) | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
US7795294B2 (en) | 2006-02-14 | 2010-09-14 | Janssen Pharmaceutica N.V. | Tetrahydro-2H-indazole pyrazole cannabinoid modulators |
US20070254911A1 (en) * | 2006-03-27 | 2007-11-01 | Mingde Xia | Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators |
KR20090120499A (ko) * | 2007-03-21 | 2009-11-24 | 얀센 파마슈티카 엔.브이. | Cb2 수용체 매개 통증의 치료 방법 |
WO2008115672A1 (en) * | 2007-03-21 | 2008-09-25 | Janssen Pharmaceutica N.V. | Method for treating cb2 receptor mediated pain |
WO2009119088A1 (ja) * | 2008-03-25 | 2009-10-01 | 武田薬品工業株式会社 | 複素環化合物 |
KR101787116B1 (ko) * | 2009-01-28 | 2017-10-18 | 케러 테라퓨틱스, 인코포레이티드 | 바이시클릭 피라졸로-헤테로사이클 |
KR101749778B1 (ko) * | 2009-08-28 | 2017-06-21 | 아레나 파마슈티칼스, 인크. | 칸나비노이드 수용체 조절제 |
CN102762575B (zh) | 2009-12-04 | 2015-04-15 | 桑诺维恩药品公司 | 多环化合物及其使用方法 |
JP6043733B2 (ja) | 2011-02-25 | 2016-12-14 | アリーナ ファーマシューティカルズ, インコーポレイテッド | カンナビノイド受容体モジュレーター |
US9458136B2 (en) * | 2011-02-25 | 2016-10-04 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of cannabinoid receptor modulators |
US9597340B2 (en) | 2011-02-25 | 2017-03-21 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
WO2012116278A1 (en) * | 2011-02-25 | 2012-08-30 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
ES2620316T3 (es) * | 2012-05-11 | 2017-06-28 | Bayer Pharma Aktiengesellschaft | Cicloalquenopirazoles sustituidos como inhibidores de BUB1 para el tratamiento del cáncer |
CA3010615C (en) | 2016-01-14 | 2024-02-20 | Beth Israel Deaconess Medical Center, Inc. | Mast-cell modulators and uses thereof |
US10196403B2 (en) | 2016-07-29 | 2019-02-05 | Sunovion Pharmaceuticals Inc. | Compounds and compositions and uses thereof |
JP2019523279A (ja) | 2016-07-29 | 2019-08-22 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 化合物および組成物ならびにそれらの使用 |
US11129807B2 (en) | 2017-02-16 | 2021-09-28 | Sunovion Pharmaceuticals Inc. | Methods of treating schizophrenia |
BR112020001433A2 (pt) | 2017-08-02 | 2020-07-28 | Sunovion Pharmaceuticals Inc. | compostos de isocromano e usos dos mesmos |
CA3091292A1 (en) | 2018-02-16 | 2019-08-22 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
US11136304B2 (en) | 2019-03-14 | 2021-10-05 | Sunovion Pharmaceuticals Inc. | Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
TWI768464B (zh) * | 2019-09-12 | 2022-06-21 | 大陸商四川海思科製藥有限公司 | 三環吡唑衍生物及其製備 |
WO2021047581A1 (zh) * | 2019-09-12 | 2021-03-18 | 四川海思科制药有限公司 | 一种六氢化苯并吡唑衍生物及其制备 |
US11738002B2 (en) | 2020-04-14 | 2023-08-29 | Sunovion Pharmaceuticals Inc. | Methods of treating neurological and psychiatric disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2742148B1 (fr) * | 1995-12-08 | 1999-10-22 | Sanofi Sa | Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2800375B1 (fr) * | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
AU2001234958A1 (en) * | 2000-02-11 | 2001-08-20 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
WO2003035005A2 (en) * | 2001-10-26 | 2003-05-01 | University Of Connecticut | Heteroindanes: a new class of potent cannabimimetic ligands |
EP1735286B1 (en) * | 2004-03-24 | 2012-01-04 | Janssen Pharmaceutica NV | Tetrahydro-indazole cannabinoid modulators |
-
2004
- 2004-09-13 FR FR0409712A patent/FR2875230A1/fr not_active Withdrawn
-
2005
- 2005-09-06 PE PE2005001028A patent/PE20060627A1/es not_active Application Discontinuation
- 2005-09-09 AR ARP050103775A patent/AR051288A1/es not_active Application Discontinuation
- 2005-09-09 UY UY29112A patent/UY29112A1/es not_active Application Discontinuation
- 2005-09-12 TW TW094131307A patent/TW200621786A/zh unknown
- 2005-09-12 WO PCT/FR2005/002255 patent/WO2006030124A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
FR2875230A1 (fr) | 2006-03-17 |
WO2006030124A1 (fr) | 2006-03-23 |
UY29112A1 (es) | 2006-04-28 |
PE20060627A1 (es) | 2006-08-15 |
TW200621786A (en) | 2006-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR051288A1 (es) | Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica | |
CR11596A (es) | Derivados de urea de tetrahidroquinoxalina, su preparacion y su aplicacion en terapeutica | |
ATE302775T1 (de) | Carbolinderivate | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
UY29388A1 (es) | Derivados del (1,5-difenil-h-pirazol-3-il)oxadiazol, su preparación y su aplicacion en terapéutica. | |
RS52534B (en) | MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS | |
AR057705A1 (es) | 3-acilaminobenzanilidas insecticidas | |
PT1332137E (pt) | Tratamento de tumores estromais gastrintestinais | |
EA201001124A1 (ru) | Производные хинолина и их применение в качестве фунгицидов | |
RS53209B (en) | PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR | |
CY1107846T1 (el) | Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες | |
AR053774A1 (es) | Derivados de sulfonilbencimidazol. composiciones farmaceuticas. | |
ATE346067T1 (de) | Carbolinderivate | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
HRP20080529T3 (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
CY2015007I1 (el) | Ενωσεις, συνθεσεις και χρησεις παραγωγων βενζοθειαζολης | |
ATE377419T1 (de) | Substituierte 4-alkoxyoxazol derivate als ppar agonisten | |
EA200700997A1 (ru) | 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ | |
HRP20080447T3 (en) | 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof | |
AR057929A1 (es) | Compuestos de amidinfenilo y su uso como fungicidas | |
DE602004024830D1 (de) | Die hiv-protease inhibierende sulfonamide | |
NO20080265L (no) | 2-(1H-indolylsulfanyl)-arylaminderivater | |
DE60220325D1 (de) | Substituierte Carbostyrilderivate als 5-HT1A-Subtyp Agonisten | |
SE0103710D0 (sv) | Compounds | |
RS52381B (en) | 2-METHYL-1- (PHENYLSULPHONYL) -4- (PIPERAZIN-1-IL) -1H-BENZIMIDAZOLE KAO 5-HYDROXYTRIPAMINE-6 LIGAND |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |